Intranasal Lipid Nanoparticles for the Treatment of Neurodegenerative Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|23|43|6553-6562

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.43, 2018-02, pp. : 6553-6562

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Lipid Nanoparticles and its Surface Modification in Reaching the Brain: An Approach for Neurodegenerative Diseases Treatment

By  

Current Drug Delivery, Vol. 15, Iss. 9, 2018-11 ,pp. : 1218-1220

Bentham Science Publishers

Access to resources Recommend Favorite

Nanoparticles, Neurotoxicity and Neurodegenerative Diseases

By  

Current Drug Metabolism, Vol. 16, Iss. 8, 2015-10 ,pp. : 676-684

Bentham Science Publishers

Access to resources Recommend Favorite

Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route

By Patel Sonal   Chavhan Sandip   Soni Heena   Babbar A.K.   Mathur Rashi   Mishra A.K.   Sawant Krutika  

Journal of Drug Targeting, Vol. 19, Iss. 6, 2011-07 ,pp. : 468-474

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Implications for Immunophilin Ligands in the Treatment of Neurodegenerative Diseases

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 6, 2003-12 ,pp. : 349-356

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting CNS Transporters for Treatment of Neurodegenerative Diseases

By  

Current Pharmaceutical Design, Vol. 20, Iss. 10, 2014-03 ,pp. : 1523-1533

Bentham Science Publishers

Access to resources Recommend Favorite